ID   FFAR4_RAT               Reviewed;         361 AA.
AC   Q2AC31;
DT   28-NOV-2006, integrated into UniProtKB/Swiss-Prot.
DT   04-APR-2006, sequence version 1.
DT   07-APR-2021, entry version 109.
DE   RecName: Full=Free fatty acid receptor 4;
DE   AltName: Full=G-protein coupled receptor 120;
DE   AltName: Full=Omega-3 fatty acid receptor 1;
GN   Name=Ffar4; Synonyms=Gpr120, O3far1;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1] {ECO:0000312|EMBL:BAE80312.1}
RP   NUCLEOTIDE SEQUENCE [MRNA].
RA   Yano T., Katsuma S., Hirasawa A., Tsujimoto G.;
RT   "Cloning and characterization of rat GPR120.";
RL   Submitted (MAR-2005) to the EMBL/GenBank/DDBJ databases.
CC   -!- FUNCTION: G-protein-coupled receptor for long-chain fatty acids (LCFAs)
CC       with a major role in adipogenesis, energy metabolism and inflammation.
CC       Signals via G-protein and beta-arrestin pathways. LCFAs sensing
CC       initiates activation of phosphoinositidase C-linked G proteins GNAQ and
CC       GNA11 (G(q)/G(11)), inducing a variety of cellular responses via second
CC       messenger pathways such as intracellular calcium mobilization,
CC       modulation of cyclic adenosine monophosphate (cAMP) production, and
CC       mitogen-activated protein kinases (MAPKs). After LCFAs binding,
CC       associates with beta-arrestin ARRB2 that acts as an adapter protein
CC       coupling the receptor to specific downstream signaling pathways, as
CC       well as mediating receptor endocytosis (By similarity). In response to
CC       dietary fats, plays an important role in the regulation of adipocyte
CC       proliferation and differentiation. Acts as a receptor for omega-3
CC       polyunsaturated fatty acids (PUFAs) at primary cilium of perivascular
CC       preadipocytes, initiating an adipogenic program via cAMP and CTCF-
CC       dependent chromatin remodeling that ultimately results in
CC       transcriptional activation of adipogenic genes and cell cycle entry.
CC       Induces differentiation of brown and beige adipocytes probably via
CC       autocrine and endocrine functions of FGF21 hormone. Contributes to the
CC       thermogenic activation of brown adipose tissue and the browning of
CC       white adipose tissue. Activates brown adipocytes by initiating
CC       intracellular calcium signaling leading to mitochondrial depolarization
CC       and fission, and overall increased mitochondrial respiration.
CC       Consequently stimulates fatty acid uptake and oxidation in mitochondria
CC       together with UCP1-mediated thermogenic respiration, eventually
CC       reducing fat mass. Regulates bi-potential differentiation of bone
CC       marrow mesenchymal stem cells toward osteoblasts or adipocytes likely
CC       by up-regulating distinct integrins. In response to dietary fats
CC       regulates hormone secretion and appetite. Stimulates GIP and GLP1
CC       secretion from enteroendocrine cells as well as GCG secretion in
CC       pancreatic alpha cells, thereby playing a role in the regulation of
CC       blood glucose levels. Negatively regulates glucose-induced SST
CC       secretion in pancreatic delta cells. Mediates LCFAs inhibition of GHRL
CC       secretion, an appetite-controlling hormone. In taste buds, contributes
CC       to sensing of dietary fatty acids by the gustatory system. During the
CC       inflammatory response, promotes anti-inflammatory M2 macrophage
CC       differentiation in adipose tissue (By similarity). Mediates the anti-
CC       inflammatory effects of omega-3 PUFAs via inhibition of NLRP3
CC       inflammasome activation (By similarity). In this pathway, interacts
CC       with adapter protein ARRB2 and inhibits the priming step triggered by
CC       Toll-like receptors (TLRs) at the level of TAK1 and TAB1 (By
CC       similarity). Further inhibits the activation step when ARRB2 directly
CC       associates with NLRP3, leading to inhibition of proinflammatory
CC       cytokine release (By similarity). Mediates LCFAs anti-apoptotic effects
CC       (By similarity). {ECO:0000250|UniProtKB:Q5NUL3,
CC       ECO:0000250|UniProtKB:Q7TMA4}.
CC   -!- SUBUNIT: Interacts (via C-terminus) with ARRB2 following LCFAs
CC       stimulation. {ECO:0000250|UniProtKB:Q5NUL3}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000250|UniProtKB:Q7TMA4};
CC       Multi-pass membrane protein {ECO:0000255}. Endosome membrane
CC       {ECO:0000250|UniProtKB:Q5NUL3}; Multi-pass membrane protein
CC       {ECO:0000255}. Lysosome membrane {ECO:0000250|UniProtKB:Q5NUL3}; Multi-
CC       pass membrane protein {ECO:0000255}. Cell projection, cilium membrane
CC       {ECO:0000250|UniProtKB:Q7TMA4}; Multi-pass membrane protein
CC       {ECO:0000255}. Note=Sorted to late endosome/lysosome compartments upon
CC       internalization (By similarity). Specifically localizes to the primary
CC       cilium of undifferentiated adipocytes. Ciliary trafficking is TULP3-
CC       dependent. As the cilium is lost during adipogenesis, moves to the
CC       plasma membrane (By similarity). {ECO:0000250|UniProtKB:Q5NUL3,
CC       ECO:0000250|UniProtKB:Q7TMA4}.
CC   -!- PTM: Phosphorylated at two clusters of Ser and Thr residues located in
CC       the intracellular C-terminus. Prerequisite for FFAR4 internalization
CC       via an ARRB2-dependent pathway. {ECO:0000250|UniProtKB:Q5NUL3}.
CC   -!- SIMILARITY: Belongs to the G-protein coupled receptor 1 family.
CC       {ECO:0000255|PROSITE-ProRule:PRU00521}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AB207868; BAE80312.1; -; mRNA.
DR   RefSeq; NP_001040553.1; NM_001047088.1.
DR   STRING; 10116.ENSRNOP00000032715; -.
DR   BindingDB; Q2AC31; -.
DR   ChEMBL; CHEMBL3309099; -.
DR   GuidetoPHARMACOLOGY; 127; -.
DR   GlyGen; Q2AC31; 1 site.
DR   PhosphoSitePlus; Q2AC31; -.
DR   PaxDb; Q2AC31; -.
DR   Ensembl; ENSRNOT00000034563; ENSRNOP00000032715; ENSRNOG00000021763.
DR   GeneID; 294075; -.
DR   KEGG; rno:294075; -.
DR   UCSC; RGD:1308252; rat.
DR   CTD; 338557; -.
DR   RGD; 1308252; Ffar4.
DR   eggNOG; KOG3656; Eukaryota.
DR   GeneTree; ENSGT01010000222342; -.
DR   HOGENOM; CLU_061487_0_0_1; -.
DR   InParanoid; Q2AC31; -.
DR   OMA; MWSPIIV; -.
DR   OrthoDB; 1057232at2759; -.
DR   PhylomeDB; Q2AC31; -.
DR   TreeFam; TF336844; -.
DR   Reactome; R-RNO-381771; Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1).
DR   Reactome; R-RNO-416476; G alpha (q) signalling events.
DR   PRO; PR:Q2AC31; -.
DR   Proteomes; UP000002494; Chromosome 1.
DR   Bgee; ENSRNOG00000021763; Expressed in colon and 20 other tissues.
DR   GO; GO:0060170; C:ciliary membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005929; C:cilium; ISS:UniProtKB.
DR   GO; GO:0030139; C:endocytic vesicle; ISO:RGD.
DR   GO; GO:0010008; C:endosome membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005887; C:integral component of plasma membrane; IBA:GO_Central.
DR   GO; GO:0005765; C:lysosomal membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005886; C:plasma membrane; ISS:UniProtKB.
DR   GO; GO:0005504; F:fatty acid binding; ISS:UniProtKB.
DR   GO; GO:0004930; F:G protein-coupled receptor activity; ISO:RGD.
DR   GO; GO:0008527; F:taste receptor activity; ISO:RGD.
DR   GO; GO:0050873; P:brown fat cell differentiation; ISS:UniProtKB.
DR   GO; GO:0045444; P:fat cell differentiation; ISO:RGD.
DR   GO; GO:0007186; P:G protein-coupled receptor signaling pathway; IDA:CACAO.
DR   GO; GO:0036321; P:ghrelin secretion; ISS:UniProtKB.
DR   GO; GO:0046879; P:hormone secretion; ISO:RGD.
DR   GO; GO:0006954; P:inflammatory response; IEA:UniProtKB-KW.
DR   GO; GO:0043066; P:negative regulation of apoptotic process; ISS:UniProtKB.
DR   GO; GO:0001818; P:negative regulation of cytokine production; ISS:UniProtKB.
DR   GO; GO:0050728; P:negative regulation of inflammatory response; ISS:UniProtKB.
DR   GO; GO:0032691; P:negative regulation of interleukin-1 beta production; ISO:RGD.
DR   GO; GO:0090275; P:negative regulation of somatostatin secretion; ISS:UniProtKB.
DR   GO; GO:0007200; P:phospholipase C-activating G protein-coupled receptor signaling pathway; ISS:UniProtKB.
DR   GO; GO:0090336; P:positive regulation of brown fat cell differentiation; ISO:RGD.
DR   GO; GO:0043950; P:positive regulation of cAMP-mediated signaling; ISS:UniProtKB.
DR   GO; GO:0120162; P:positive regulation of cold-induced thermogenesis; ISS:YuBioLab.
DR   GO; GO:0007204; P:positive regulation of cytosolic calcium ion concentration; ISO:RGD.
DR   GO; GO:0070374; P:positive regulation of ERK1 and ERK2 cascade; ISS:UniProtKB.
DR   GO; GO:0070094; P:positive regulation of glucagon secretion; ISS:UniProtKB.
DR   GO; GO:0045669; P:positive regulation of osteoblast differentiation; ISS:UniProtKB.
DR   GO; GO:0010827; P:regulation of glucose transmembrane transport; ISS:UniProtKB.
DR   GO; GO:0050872; P:white fat cell differentiation; ISS:UniProtKB.
DR   InterPro; IPR000276; GPCR_Rhodpsn.
DR   InterPro; IPR017452; GPCR_Rhodpsn_7TM.
DR   Pfam; PF00001; 7tm_1; 1.
DR   PRINTS; PR00237; GPCRRHODOPSN.
DR   PROSITE; PS50262; G_PROTEIN_RECEP_F1_2; 1.
PE   2: Evidence at transcript level;
KW   Cell membrane; Cell projection; Differentiation; Disulfide bond; Endosome;
KW   G-protein coupled receptor; Glycoprotein; Inflammatory response;
KW   Lipid-binding; Lysosome; Membrane; Phosphoprotein; Receptor;
KW   Reference proteome; Transducer; Transmembrane; Transmembrane helix.
FT   CHAIN           1..361
FT                   /note="Free fatty acid receptor 4"
FT                   /id="PRO_0000262961"
FT   TOPO_DOM        1..45
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        46..66
FT                   /note="Helical; Name=1"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        67..77
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        78..98
FT                   /note="Helical; Name=2"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        99..103
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        104..124
FT                   /note="Helical; Name=3"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        125..156
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        157..177
FT                   /note="Helical; Name=4"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        178..204
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        205..225
FT                   /note="Helical; Name=5"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        226..268
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        269..289
FT                   /note="Helical; Name=6"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        290..295
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        296..316
FT                   /note="Helical; Name=7"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        317..361
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   MOD_RES         347
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:Q5NUL3"
FT   MOD_RES         349
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:Q5NUL3"
FT   MOD_RES         350
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q5NUL3"
FT   MOD_RES         357
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q5NUL3"
FT   MOD_RES         360
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q5NUL3"
FT   CARBOHYD        21
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   DISULFID        111..194
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00521"
SQ   SEQUENCE   361 AA;  40902 MW;  8444F22C1CB7DC0F CRC64;
     MSPECAQTTG PGPSRTPDQV NRTHFPFFSD VKGDHRLVLS VLETTVLGLI FVVSLLGNVC
     ALVLVVRRRR RGATVSLVLN LFCADLLFTS AIPLVLVVRW TEAWLLGPVV CHLLFYVMTM
     SGSVTILTLA AVSLERMVCI VRLRRGLSGP GRRTQAALLA FIWGYSALAA LPLCILFRVV
     PQRLPGGDQE IPICTLDWPN RIGEISWDVF FVTLNFLVPG LVIVISYSKI LQITKASRKR
     LTLSLAYSES HQIRVSQQDY RLFRTLFLLM VSFFIMWSPI IITILLILIQ NFRQDLVIWP
     SLFFWVVAFT FANSALNPIL YNMSLFRSEW RKIFCCFFFP EKGAIFTETS IRRNDLSVIS
     T
//
